[an error occurred while processing this directive]

Journal of Chinese Integrative Medicine ›› 2005, Vol. 3 ›› Issue (4): 290-293.doi: 10.3736/jcim20050413

• Original Experimental Research • Previous Articles     Next Articles

Effects of Huatan Xiezhuo Recipe on insulin resistance and leptin in rats with fatty liver

Fang Ye1,Wen-xia Zhao2(),Ming-san Miao2,Jian-guo Li2,Yong-yan Zhang2   

  1. 1. First Clinical College, Nanjing University of Traditional Chinese Medicine, Nanjing, Jiangsu Province 210029, China
    2. Institute of Liver Diseases, Henan College of Traditional Chinese Medicine, Zhengzhou, Henan Province 450008, China
  • Received:2004-09-20 Online:2005-07-20 Published:2005-07-20
  • Contact: Wen-xia Zhao E-mail:zhao8536@hotmail.com

RichHTML

2

PDF (PC)

128

Like

Objective

To observe the effects of Huatan Xiezhuo Recipe (HTXZR) on fatty liver of rats.

Methods

Forty-eight SD rats were randomly divided into five groups: normal control group, untreated group, Dongbao Gantai Tablet (DBGTT)-treated group, low-dose HTXZR-treated group and high-dose HTXZR-treated group. Fatty liver was induced in the rats by hyperlipid diet and intraperitoneal injection of tetracycline. The pathological changes of liver tissues in rats were observed, and the liver function, serum leptin, insulin resistance index, triglyceride (TG) and free fatty acid (FFA) in the liver were detected.

Results

The levels of serum leptin, insulin resistance index, FFA and TG in rats of the three treated groups were lower than those of the untreated group (P<0.01), and such effects in the HTXZR-treated groups were more significant than those in the DBGTT-treated group (P<0.05).

Conclusion

The main action mechanisms of HTXZR in treating fatty liver are probably to promote the lipid metabolism, decrease the leptin and insulin resistance.

Key words: Huatan Xiezhuo Recipe, Fatty liver, Free fatty acid, Insulin resistance, Leptin resistance

CLC Number: 

  • R589.2

Tab 1

Changes of liver weight and liver index of the rats ($\bar{x}$±s)"

Group n Body weight (g) Liver index (%)
Normal control group 8 275.8±7.9 3.02±0.17
Untreated group 9 333.6±15.2▲▲ 4.10±0.24▲▲
DBGTT-treated group 10 311.0±10.7*▲▲ 3.80±0.20*▲▲
Low-dose HTXZR-treated group 10 300.6±12.8*▲▲ 3.55±0.17*△▲▲
High-dose HTXZR-treated group 10 283.5±11.1*▲▲ 3.68±0.16*▲▲

Tab 2

Changes of serum ALT, AST, leptin and insulin resistance index of the rats ($\bar{x}$±s)"

Group n ALT (U/L) AST (U/L) Leptin (μg/L) Insulin resistance index
Normal control group 8 48.88±4.76 149.75±5.37 0.29±0.06 9.94±0.81
Untreated group 9 425.87±72.93 292.12±30.99 1.08±0.37 14.69±1.93
DBGTT-treated group 10 212.13±19.17* 249.63±27.60 0.86±0.20 12.44±1.62*
Low-dose HTXZR-treated group 10 167.11±24.44*△△ 188.44±25.52*△△ 0.69±0.19* 14.10±2.63
High-dose HTXZR-treated group 10 150.88±19.31**△△ 204.50±15.90**△△ 0.62±0.16*△ 12.84±1.79*

Tab 3

Changes of liver tissue FFA, TG and serum TG of the rats ($\bar{x}$±s)"

Group n Liver homogenate FFA
(μmol/g)		 Liver omogenate TG
(mmol/L)		 Serum TG
(mmol/L)
Normal control group 8 123.71±16.37 0.56±0.05 0.85±0.19
Untreated group 9 560.50±81.67 7.38±0.55 1.49±0.45
DBGTT-treated group 10 382.73±36.71** 5.19±0.52** 1.47±0.44
Low-dose HTXZR-treated group 10 324.46±34.51**△△ 4.68±0.43**△ 1.26±0.34
High-dose HTXZR-treated group 10 280.51±14.78**△△ 3.77±0.31**△△ 1.43±0.31
[1] 杨正武, 魏良州 . 瘦素抵抗、胰岛素抵抗与非酒精性脂肪肝病[J]. 医学综述, 2004,10(6):335-338
doi: 10.3969/j.issn.1006-2084.2004.06.008
[2] 吴木潮 . 瘦素与代谢综合征[J]. 国外医学·内科学分册, 2000,27(12):519-521
[3] 钟岚, 范建高, 王国良 , 等. 肥胖、高脂血症性脂肪肝肝炎模型的建立[J]. 实验动物科学与管理, 2000,17(2):16-20
[4] 李光伟 . 当前胰岛素敏感性评估及胰岛素抵抗研究的某些误区[J]. 中华内科杂志, 1998,37(2):81-83
[5] 孙丽伟, 陈芝芸, 严茂祥 , 等. 高脂饮食脂肪肝大鼠血清TNF-α、IL-6、Leptin的变化[J]. 浙江中医学院学报, 2004,28(3):41-42
[6] 梁坚, 王婉梅, 揭育丽 , 等. 脂肪肝患者血清瘦素与胰岛素抵抗的关系[J]. 中国临床康复, 2004,8(27):5847-5849
[7] 黄伟, 季峰, 姜玲玲 , 等. 脂肪肝患者血清瘦素水平检测及其与发病的关系[J]. 中华检验医学杂志, 2004,27(2):106
[1] Di Li, Guan-liang Wang, Meng-ya Shan, Jia-han Liu, Lin Wang, De-zeng Zhu. Effects of ursolic acid on c-Cbl-associated protein expression in 3T3-L1 adipocytes with insulin resistance. Journal of Chinese Integrative Medicine, 2012, 10(8): 886-893.
[2] Dong-mei Zhang, Li-xia Lou, Ai-ming Wu, Xi-ying Lü, Zhao-juan Hu, Yan-hong Zhang, Hong-fang Liu. Effects of Astragalus membranaceus and Potentilla discolor mixture on insulin resistance and its related mRNA expressions in KKAy mice with type 2 diabetes. Journal of Chinese Integrative Medicine, 2012, 10(7): 821-826.
[3] Lin Wang, Guan-liang Wang, Jia-han Liu, Di Li, De-zeng Zhu, Liang-neng Wu . Effects of ursolic acid in ameliorating insulin resistance in liver of KKAy mice via peroxisome proliferator-activated receptors α and γ. Journal of Chinese Integrative Medicine, 2012, 10(7): 793-799.
[4] Mao Zhi-min, Song Hai-yan, Yang Li-li, Liu Tao, Li Dong-fei, Zheng Pei-yong, Liu Ping, Ji Guang. Effects of the mixture of Swertia pseudochinensis Hara and Silybum marianum Gaertn extracts on CCl4-induced liver injury in rats with non-alcoholic fatty liver disease. Journal of Chinese Integrative Medicine, 2012, 10(2): 193-199.
[5] Tao Liu , Li-li Yang , Li Zhang, Hai-yan Song , Dong-fei Li , Guang li. Comparative study on the effects of different therapeutic methods in preventing and treating nonalcoholic fatty liver in rats. Journal of Chinese Integrative Medicine, 2012, 10(10): 1120-1126.
[6] Liu Yue, Xie Ming, Zhang Ye. Dynamic changes of laboratory parameters of rats with type 2 diabetes and insulin resistance: defining their role in development of traditional Chinese medicine syndrome. Journal of Chinese Integrative Medicine, 2012, 10(1): 100-108.
[7] Li-li Yang, Miao Wang, Tao Liu, Hai-yan Song, Dong-fei Li, Pei-yong Zheng, Ping Liu, Guang Ji. Effects of Chinese herbal medicine Jiangzhi Granule on expressions of liver X receptor α and sterol regulatory element-binding protein-1c in a rat model of non-alcoholic fatty liver disease. Journal of Chinese Integrative Medicine, 2011, 9(9): 998-1004.
[8] Susuana Kuek, Wen-jun Wang, Sui-qi Gui. Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2011, 9(9): 965-972.
[9] Tao Liu, Zhi-peng Tang, Guang Ji. Treatment of non-alcoholic fatty liver disease based on traditional Chinese medicine therapies for warming yang to activate qi. Journal of Chinese Integrative Medicine, 2011, 9(2): 135-137.
[10] Xiang-yu Guo, Ying Duan, Juan-e Li , Li-xia Yang, Lian-sha Huang, Zhi-cheng Wang, He-yao Wang, Tong-hua Liu. Antidiabetic effects of Tangnaikang on obese Zucker rats and the mechanism. Journal of Chinese Integrative Medicine, 2010, 8(6): 535-540.
[11] Ping Xie, Xin-xi Zhou, Qin Zhang. Pathogenesis and treatment of non-alcoholic fatty liver disease. Journal of Chinese Integrative Medicine, 2010, 8(3): 201-209.
[12] Guang Ji . Pay attention to insulin resistance in chronic liver diseases. Journal of Chinese Integrative Medicine, 2010, 8(1): 1-6.
[13] Hong-shan Li, Qin Feng, Li-li Xu, Shao-dong Chen, Xue-mei Li, Yi-yang Hu. Effects of Qushi Huayu Decoction in prevention and treatment of fatty liver in rats based on adiponection-free fatty acid pathway. Journal of Chinese Integrative Medicine, 2009, 7(6): 546-551.
[14] Hua-feng Wei, Tao Liu, Lian-jun Xing, Pei-yong Zheng, Guang Ji. Distribution pattern of traditional Chinese medicine syndromes in 793 patients with fatty liver disease. Journal of Chinese Integrative Medicine, 2009, 7(5): 411-417.
[15] Hui Zhang, Qin Feng, Hong-shan Li, Shao-dong Chen, Xiao-ning Wang, Jing-hua Peng, Ning Zhang, Yi-yang Hu. Effects of Qushi Huayu Decoction on cathepsin B and tumor necrosis factor-α expression in rats with non-alcoholic steatohepatitis. Journal of Chinese Integrative Medicine, 2008, 6(9): 928-933.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[2] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[3] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[4] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[5] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[6] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[7] Li Zhou, Hong-xing Zhang, Ling-guang Liu, Wen-jun Wan. Effect of electro-acupuncture at Fenglong (GV 16) on nitric oxide and endothelin in rats with hyperlipidemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 89-92
[8] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[9] Xin-jun Wang, Ling-ling Wang . A mechanism of endogenous opioid peptides for rapid onset of acupuncture effect in treatment of depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1014-1017
[10] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022
[an error occurred while processing this directive]